Trials / Conditions / Substance Abuse, Intravenous

Substance Abuse, Intravenous

14 registered clinical trials studyying Substance Abuse, Intravenous.

Status	Trial	Sponsor	Phase
Completed	Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders NCT04556552	Emory University	Phase 3
Completed	Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care NCT03093415	Oregon Health and Science University	Phase 4
Completed	BRIDGE: Improving HIV Service Delivery for People Who Inject Drugs NCT02796027	Columbia University	N/A
Completed	Break the Cycle: Prevention for Reducing Initiation Into Injection Drug Use NCT03502525	New York University	N/A
Completed	Change the Cycle: An RCT to Prevent Injection Initiation NCT02774954	University of Southern California	N/A
Completed	Conflict Between Maternal Autonomy and Child Health in Substance-use NCT02797990	London School of Hygiene and Tropical Medicine	—
Completed	The Long-Term Treatment of Drug Addiction and Unemployment NCT02487745	Johns Hopkins University	N/A
Completed	Contingency Management in the Delivery of HAART to Drug Users in Chennai, India NCT01031745	Johns Hopkins University	Phase 2
Completed	Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care NCT00471042	New York State Psychiatric Institute	—
Completed	Employment-based Reinforcement of Naltrexone Ingestion and Abstinence NCT00149669	Johns Hopkins University	N/A
Completed	Post-marketing Surveillance Study of Ex-intravenous Drug Abusers With Chronic Hepatitis C Treated With PegIntr NCT00726557	Merck Sharp & Dohme LLC	—
Completed	A Randomized Trial of Vaccine Adherence in Young Injection Drug Users NCT00244374	University of California, San Francisco	N/A
Completed	The Therapeutic Workplace Initiation Study NCT00249470	Johns Hopkins University	N/A
Completed	Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 NCT00023283	Yale University	Phase 2